RCUS

15.6600.76%
RA

Richard A. Markus

Chief Medical Officer

Dr. Richard A. Markus MD, PhD, is Chief Medical Officer of Arcus Biosciences, Inc. from 2025. Dr. Markus is President & CEO of Dantari, Inc. Dr. Markus's extensive late-stage development experience be essential as he leads Arcus???s strategy and efforts to fully leverage the opportunities in Arcus???s portfolio. Dr. Markus established a unique track record of late-stage development experience during a 13-year tenure at Amgen in increasing roles of responsibility, including as vice president of global development. Dr. Markus oversaw the development and approval of multiple products and was also the first R&D head for the biosimilars division, leading the development of a 10-product pipeline across multiple therapeutic areas, including oncology and rheumatology. Most recently. Dr. Markus founded Dantari, a clinical-stage oncology-focused antibody-drug conjugate company, where he served as president, CEO and member of the Board. Dr. Markus earned his medical degree and a Ph.D. in epidemiology from the University of Southern California and then his surgery internship and residency in urology.

Positions